Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,69 USD | +7,17 % | +16,30 % | +106,25 % |
Resumen de negocios
Número de empleados: 30
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joseph Hagan
CEO | Chief Executive Officer | 55 | 04/01/16 |
Preston Klassen
PSD | President | 55 | 22/06/23 |
Crispina Calsada
DFI | Director of Finance/CFO | 54 | 30/08/19 |
Chief Tech/Sci/R&D Officer | - | 29/11/22 | |
Rekha Garg
LAW | General Counsel | - | 29/11/22 |
Amin Kamel
PRN | Corporate Officer/Principal | - | 02/06/22 |
Daniel Penksa
AUD | Comptroller/Controller/Auditor | 39 | 01/06/15 |
Christopher Aker
LAW | General Counsel | 63 | 19/05/11 |
Brian K. Campion
PRN | Corporate Officer/Principal | - | 01/07/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 01/06/17 |
David Baltimore
BRD | Director/Board Member | 86 | 01/01/09 |
Director/Board Member | 75 | 01/04/13 | |
Chairman | 74 | 01/01/08 | |
Jake Nunn
BRD | Director/Board Member | 54 | 11/06/19 |
Alice S. Huang
BRD | Director/Board Member | 85 | 26/01/21 |
Hugh Rosen
BRD | Director/Board Member | 64 | 02/06/16 |
Joseph Hagan
CEO | Chief Executive Officer | 55 | 04/01/16 |
Preston Klassen
PSD | President | 55 | 22/06/23 |
Director/Board Member | 56 | 17/04/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 3 725 720 | 0 | 0 | 95,99 % |
Acción B | 0 | 258 707 | 0 | 0 | |
Acción C | 0 | 1 330 832 | 0 | 0 | |
Acción D | 1 | 65 465 251 | 64 363 054 ( 98,32 %) | 0 | |
Acción E | 0 | 256 700 | 0 | 0 |
Información de la empresa
Regulus Therapeutics, Inc.
4224 Campus Point Court Suite 210
92121, San Diego
+858 202 6300
http://www.regulusrx.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+106,25 % | 164 M | |
-1,33 % | 104 mil M | |
+4,20 % | 97,47 mil M | |
+5,82 % | 22,25 mil M | |
-13,41 % | 21,68 mil M | |
-9,70 % | 18,2 mil M | |
-39,98 % | 17,02 mil M | |
-11,72 % | 16,36 mil M | |
+8,38 % | 14,39 mil M | |
+41,43 % | 12,37 mil M |
- Bolsa de valores
- Acciones
- Acción RGLS
- Empresa Regulus Therapeutics Inc.